| Campo DC | Valor | Idioma |
|---|
| dc.contributor.author | Paniágua, Aline Lorenzoni | - |
| dc.contributor.author | Correia, Amabel Fernandes | - |
| dc.contributor.author | Pereira, Lívia Custódio | - |
| dc.contributor.author | Alencar, Bruna Maciel de | - |
| dc.contributor.author | Silva, Fabiana Brandão Alves | - |
| dc.contributor.author | Almeida, Rosane Mansan | - |
| dc.contributor.author | Nóbrega, Yanna Karla de Medeiros | - |
| dc.date.accessioned | 2022-04-20T12:32:44Z | - |
| dc.date.available | 2022-04-20T12:32:44Z | - |
| dc.date.issued | 2021-09-23 | - |
| dc.identifier.citation | Paniágua, Aline Lorenzoni et al. Inhibitory effects of Lactobacillus casei Shirota against both Candida auris and Candida spp. isolates that cause vulvovaginal candidiasis and are resistant to antifungals. BMC Complementary Medicine and Therapies, v. 21, 237, 2021. DOI: https://doi.org/10.1186/s12906-021-03405-z. Disponível em: https://bmccomplementmedtherapies.biomedcentral.com/articles/10.1186/s12906-021-03405-z. Acesso em: 20 abr. 2022. | pt_BR |
| dc.identifier.uri | https://repositorio.unb.br/handle/10482/43510 | - |
| dc.language.iso | Inglês | pt_BR |
| dc.publisher | BMC | pt_BR |
| dc.rights | Acesso Aberto | pt_BR |
| dc.title | Inhibitory effects of Lactobacillus casei Shirota against both Candida auris and Candida spp. isolates that cause vulvovaginal candidiasis and are resistant to antifungals | pt_BR |
| dc.type | Artigo | pt_BR |
| dc.subject.keyword | Candidíase | pt_BR |
| dc.subject.keyword | Candida spp | pt_BR |
| dc.subject.keyword | Lactobacillus | pt_BR |
| dc.subject.keyword | Biofilme | pt_BR |
| dc.subject.keyword | Antifúngicos | pt_BR |
| dc.rights.license | © The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. | pt_BR |
| dc.identifier.doi | https://doi.org/10.1186/s12906-021-03405-z | pt_BR |
| dc.description.abstract1 | Background
Vulvovaginal candidiasis (VVC), the second leading cause of genital infection in women of reproductive age, is caused by yeasts of the genus Candida. Treatment is usually empirical and performed with azoles, which have shown increasing ineffectiveness due to resistance from these species. This therapeutic challenge has led to the search for new treatment strategies. Lactobacillus spp. produce several components with microbicidal effects, such as lactic acid. These species are the main components of a healthy vaginal microbiota and have been used as probiotics. The aim of this work was to investigate the in vitro inhibitory effects of Lactobacillus casei Shirota on both the Candida spp. that cause VVC and on C. auris.
Methods
The microbicidal effects of L. casei Shirota on the main VVC-causing species, C. albicans, C. tropicalis, C. norvegensis and C. parapsilosis, in addition to C. auris were investigated by counting the Colony-forming Units (CFUs) after cocultivation. The antifungal activity of lactic acid against these Candida strains was assessed using the microtiter broth dilution method to determine the minimum inhibitory concentrations (MICs). The effects of L. casei Shirota on hyphal and early biofilm formation was measured by optical microscopy.
Results
L. casei Shirota showed inhibitory action against all tested Candida spp., ranging from 66.9 to 95.6% inhibition depending on the species. This inhibition is possibly related to the production of lactic acid, since lactic acid has shown microbicidal action against these same Candida spp. at a concentration of 5 mg/mL, which corresponds to half of the normal physiological concentration. In addition, L. casei Shirota was able to reduce the formation of C. albicans hyphae and early biofilms, showing strong anti-Candida effects.
Conclusions
These results suggest that L. casei Shirota has antifungal activity against the Candida species that cause VVC. L. casei also has microbicidal action against C. auris. | pt_BR |
| dc.identifier.orcid | https://orcid.org/ 0000-0003-4179-8533 | pt_BR |
| Aparece nas coleções: | Artigos publicados em periódicos e afins
|
